Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor PrognosisFrancesco Iovino, Michele Orditura, Giuliano Antoniol et al.|Journal of Clinical Medicine|2022Cited by 13
Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine TherapyLuca Scafuri, Giuseppe Di Lorenzo, Carlo Buonerba et al.|Oncology and Therapy|2024Cited by 0